跳至主要内容
临床试验/ACTRN12613001042730
ACTRN12613001042730已完成4 期

A single-centred randomised double-blind pilot trial investigating acute kidney injury (RIFLE-criteria) from either 0.9% saline or Plasmalyte (Registered Trademark) 148 solutions as fluid therapy in adult patients undergoing major surgery

Austin Hospital0 个研究点目标入组 1,100 人开始时间: 2013年9月19日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
1,100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients aged greater than 18 years admitted to the Austin Hospital who are undergoing surgery.

排除标准

  • 1. Patients who are <18 years in age
  • 2. Raised intracranial pressure (these patients may specific fluid intervention strategies to prevent further increases in intracranial pressure)
  • 3. Patients undergoing liver transplantation (these patients require non- lactated crystalloid solutions as part of the Austin Hospital perioperative fluid intervention protocol.
  • 4. Patients undergoing renal transplantation, as these patients are currently part of a current randomised clinical trial.

研究者

发起方
Austin Hospital

相似试验